AME Logo

Related Materials

17th International Workshop on Pediatrics & HIV 2025

Show local (UTC) times

08:00

Opening of the Workshop

08:00

Opening Words

08:15

Social Opening from the Local Co-Chairs

08:30

Session 1: Global Update on Pediatric HIV

08:30

Session Chair:

08:30

Global Update on the HIV Epidemic in Infants, Children, Adolescents, and Women

08:45

Rwanda Response to Maternal and Pediatric HIV

09:00

Discussion | Session 1

09:15

Oral Abstract Presentations I

09:15

#1 Gestational Exposure to an Efavirenz-Containing Compared to a Dolutegravir-Containing Antiretroviral Regimen Is Associated with Lower Anthropometrics at 18 Months of Life among Children HIV-Exposed Uninfected in Botswana

Abstract

09:30

#2 Infant Safety Following Exposure to Maternal TDF/FTC for HIV Prevention in Utero and Through Breast Milk: IMPAACT 2009

Abstract

09:45

#3 The Impact of Daily Oral PrEP on Maternal Bone Mineral Density During Pregnancy and Postpartum: IMPAACT 2009

Abstract

10:00

#4 Impact of Maternal HIV Status on Maternal and Child Peripheral Blood Immune Markers and Associations with Neurometabolite Profiles at Age 6–7 Years: A South African Birth Cohort Study

Abstract

10:15

#5 Validation of a Ministry of Health (MoH) HIV Risk Screening Tool for Breastfeeding Women (BFW) in Northern and Central Mozambique (2022 to 2024)

Abstract

10:30

AM Break | Day 1

11:00

Session 2: Prevention of New Paediatric HIV Infections (and Improving Maternal Health)

11:00

Session Chair:

11:00

Long-Acting PrEP Options for HIV Prevention, Including During Pregnancy and Breastfeeding

11:15

Potential Models for Infant Antiretroviral Prophylaxis to Prevent Perinatal/Postnatal Transmission

11:30

What Do We Know About Choice of Antiretrovirals for Infant Prophylaxis to Prevent Transmission?

11:45

Discussion | Session 2

12:00

Lunch & Poster Viewing | Day 1

13:30

Session 3: Adolescents and Young Adults

13:30

Session Chair:

13:30

The Science of Premature Aging in Youth with Perinatal HIV Infection

13:45

The Clinical Consequences of Premature Aging in Youth with Perinatal HIV Infection

14:00

Discussion | Session 3

14:15

Youth Panel: New Platforms, New Possibilities - Supporting Adolescents Living with HIV in a Digital World

14:15

Moderator

15:15

PM Break | Day 1

15:45

Oral Abstract Presentations II

15:45

#6 Did HIV-1 Incidence Decline During the DREAMS Program? Lack of Progress for Adolescent Girls and Young Women

Abstract

16:00

#7 Ugandan Teenage Females with PHIV on DTG Have a Distinct Phenotype Concerning for Future Cardiometabolic Risk

Abstract

16:15

#8 Minimising Risk, Maximising Retention: A Cascade Analysis of Vertical HIV Transmission Prevention among Adolescent Mothers and Their Children in the Eastern Cape Province, South Africa

Abstract

16:30

#9 Mental Health Challenges and Substance Use Associated with Poor Viral Suppression and Transition Readiness among Adolescents with HIV Transitioning to Adult Care

Abstract

16:45

#10 Outcomes of Children and Young Adolescents Receiving ART Under Family-Based DSD Model at Largest Public ART Clinic in Lilongwe, Malawi

Abstract

17:15

Poster Walk #1: Pregnancy and Perinatal Transmission

17:15

Lead Moderator:

17:15

Poster Walk #2: Pediatric Treatment

17:15

Lead Moderator:

17:15

Poster Walk #3: Adolescents

17:15

Lead Moderator:

17:15

Poster Walk #4: Co-Infections/Comorbidities

17:15

Lead Moderator:

19:00

Workshop Dinner (pre-registration required)